Literature DB >> 12110902

Emerging clinical applications of RNA.

Bruce A Sullenger1, Eli Gilboa.   

Abstract

RNA is a versatile biological macromolecule that is crucial in mobilizing and interpreting our genetic information. It is not surprising then that researchers have sought to exploit the inherent properties of RNAs so as to interfere with or repair dysfunctional nucleic acids or proteins and to stimulate the production of therapeutic gene products in a variety of pathological situations. The first generation of the resulting RNA therapeutics are now being evaluated in clinical trials, raising significant interest in this emerging area of medical research.

Mesh:

Substances:

Year:  2002        PMID: 12110902     DOI: 10.1038/418252a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  64 in total

1.  Functional repair of a mutant chloride channel using a trans-splicing ribozyme.

Authors:  Christopher S Rogers; Carlos G Vanoye; Bruce A Sullenger; Alfred L George
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 2.  RNA interference: biology, mechanism, and applications.

Authors:  Neema Agrawal; P V N Dasaradhi; Asif Mohmmed; Pawan Malhotra; Raj K Bhatnagar; Sunil K Mukherjee
Journal:  Microbiol Mol Biol Rev       Date:  2003-12       Impact factor: 11.056

3.  Cytoplasmic expression of EGFP in dendritic cells transfected with in vitro transcribed mRNA or cellular total RNA extracted from EGFP expressing leukemia cells.

Authors:  Masuhiro Takahashi; Miwako Narita; Flavio Ayres; Naoko Satoh; Takashi Abe; Toshio Yanao; Tatsuo Furukawa; Ken Toba; Takeshi Hirohashi; Yoshifusa Aizawa
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

4.  Maxizyme-mediated specific inhibition on mutant-type p53 in vitro.

Authors:  Xin-Juan Kong; Yu-Hu Song; Ju-Sheng Lin; Huan-Jun Huang; Nan-Xia Wang; Nan-Zhi Liu; Bin Li; You-Xin Jin
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

5.  Single-molecule transition-state analysis of RNA folding.

Authors:  Gregory Bokinsky; David Rueda; Vinod K Misra; Maria M Rhodes; Andrew Gordus; Hazen P Babcock; Nils G Walter; Xiaowei Zhuang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-17       Impact factor: 11.205

Review 6.  Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing.

Authors:  Mariano A Garcia-Blanco
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

Review 7.  Gene targeting: roadmap to future therapies.

Authors:  Lars C Huber; Thomas Pap; Ulf Müller-Ladner; Renate E Gay; Steffen Gay
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

Review 8.  Induction of RNA interference in dendritic cells.

Authors:  Mu Li; Hua Qian; Thomas E Ichim; Wei-Wen Ge; Igor A Popov; Katarzyna Rycerz; John Neu; David White; Robert Zhong; Wei-Ping Min
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 9.  Convergent evolution of twintron-like configurations: One is never enough.

Authors:  Mohamed Hafez; Georg Hausner
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

10.  HIV-1 Nef-associated Factor 1 Enhances Viral Production by Interacting with CRM1 to Promote Nuclear Export of Unspliced HIV-1 gag mRNA.

Authors:  Xiao-Xin Ren; Hai-Bo Wang; Chuan Li; Jin-Feng Jiang; Si-Dong Xiong; Xia Jin; Li Wu; Jian-Hua Wang
Journal:  J Biol Chem       Date:  2016-01-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.